Wordt geladen...
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
Hydroxychloroquine and chloroquine, also known as antimalarial drugs, are widely used in the treatment of rheumatic diseases and have recently become the focus of attention because of the ongoing COVID-19 pandemic. Rheumatologists have been using antimalarials to manage patients with chronic immune-...
Bewaard in:
| Gepubliceerd in: | Adv Rheumatol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7282202/ https://ncbi.nlm.nih.gov/pubmed/32517786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42358-020-00134-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|